131I 治疗Graves病43例疗效分析

J4 ›› 2010, Vol. 9 ›› Issue (2): 33-34.

¹³¹I 治疗Graves病43例疗效分析

大理学院大理附属医院核医学科，云南大理 671000

收稿日期:2009-06-05 修回日期:2009-10-21 出版日期:2010-02-15 发布日期:2010-02-15
作者简介:汤建林，副主任医师，主要从事临床核医学研究.

An Analysis of 43 Cases of Graves Disease Treated with ¹³¹I

Department of Nuclear Medicine, Dali Affiliated Hospital，Dali University, Dali, Yunnan 671000, China

Received:2009-06-05 Revised:2009-10-21 Online:2010-02-15 Published:2010-02-15

摘要/Abstract

摘要：

目的：探讨¹³¹I治疗Graves病的临床应用价值。方法：通过对43例确诊Graves病具有适应症患者，采用以¹³¹I为主的综合治疗，治疗后定期随访并进行疗效评价。结果：均无早期不良反应发生，随访4~19月，治愈27例，治愈率62.8%，明显好转15例，有效率97.7%，无效1例，无效率2.3%。甲状腺体积明显缩小。结论：¹³¹I治疗Graves病安全高效，有良好的应用前景。

关键词: Graves病, 甲状腺功能亢进, ¹³¹I治疗

Abstract:

Objective: To analyze the results of the treatment of ¹³¹I therapy for Graves disease in this region. Methods: 43 cases of Graves disease were treated with 131I-based integrated treatment and regular follow-up was accompanied to evaluate the efficacy after treatment. Results: No adverse reactions occurred in the early period. In the follow-up from 4 to 19 months, 27 cases were cured, the cure rate being 62.8%; there was significant improvement in 15 cases, efficiency being 97.7%; 1 case is invalid, ineffective rate being 2.3%. The thyroid volume was significantly reduced. Conclusion: It is safe and effective to treat Graves disease with ¹³¹I therapy, and it has a good application prospect.

Key words: Graves disease, hyperthyroidism, ¹³¹I therapy

中图分类号:

R817.8

汤建林, 李玉莹, 高柳艳, 唐秀萍, 汪慧茹, 李月秋. ¹³¹I 治疗Graves病43例疗效分析[J]. J4, 2010, 9(2): 33-34.

TANG Jian-Lin, LI Yu-Ying, GAO Liu-Yan, TANG Xiu-Ping, WANG Hui-Ru, LI Yue-Qiu. An Analysis of 43 Cases of Graves Disease Treated with ¹³¹I[J]. J4, 2010, 9(2): 33-34.

参考文献

〔1〕邢家骝.131碘治疗甲状腺疾病〔M〕.北京：人民卫生出版社，
2002：152.

〔2〕高妍.应用基础研究指导临床实践，提高Graves病的长期
缓解率〔J〕.中华内分泌代谢杂志，1995，11（3）：131-132.
〔3〕中华医学会内分泌学分会《中国甲状腺疾病诊治指南》
编写组.中国甲状腺疾病诊治指南———甲状腺功能亢进
症〔J〕.中华内科杂志，2007（10）：876-882.
〔4〕张永学.核医学〔M〕.北京：人民卫生出版社，2005：353-
358.
〔5〕Ron E，Doody MM，Becker DV，et al. Cancer mortality
following treatment for adult hyperthyroidism〔J〕. JAMA，
1998，280：347-355.
〔6〕马寄晓，刘秀杰.实用临床医学〔M〕.2版，北京：原子能出
版社，2002：471-482.
〔7〕邢家骝.131I治疗甲状腺功能亢进症对性腺的影响〔J〕.中
华内分泌代谢杂志，2007，23（6）：481-483.
〔8〕Rudbery C，Jahanson H，Akerstrom G，et al. Graves
disease in children and adolescents，Late results of
surgical treatment〔J〕. Eur J Endocrinol，1996，134：710-
715.
〔9〕Read CH Jr， Tansey MJ， Menda Y. A 36 -year
retrospectiveanalysisoftheefficacyandsafetyofradioactive
iodine in treating yong Graves' patients〔J〕. J Clin
Endocrinol Metab，2004，89：4229-4233.
〔10〕汤建林，李玉莹，高柳艳，等. 甲状腺功能亢进症治疗方
法的比较和选择〔J〕.国际放射医学核医学杂志，2009，
33（3）：175-178.
〔11〕初玲华.¹³¹I治疗Graves病的进展〔J〕.大理学院学报，2002，
1（3）：90-92.
〔12〕陈文贤，颜兵，董延武，等. 抗甲状腺药物和131陨碘治疗甲
亢的医疗成本分析〔J〕.中国卫生事业管理，1999（6）：
302-305.
〔13〕Singer PA，Cooper DS，Levy EC，et al. Treatment
guidelines for patients with hyperthyroidism and hy
pothyroidism〔J〕. JAMA，1995，273：808-812.

¹³¹I 治疗Graves病43例疗效分析

An Analysis of 43 Cases of Graves Disease Treated with ¹³¹I

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价